Degarelix Monotherapy Compared With Luteinizing Hormone-Releasing Hormone (LHRH) Agonists Plus Anti-Androgen Flare Protection in Advanced Prostate Cancer: An Analysis of Two Randomized Controlled Trials
Therapeutic Advances in Urology - United States
doi 10.1177/1756287215621471
Full Text
Open PDFAbstract
Available in full text
Categories
Date
December 16, 2015
Authors
Publisher
SAGE Publications